Objective: We used functional MRI (fMRI) and a left-lateralizing verbal and a right-lateralizing visual-spatial working memory (WM) paradigm to investigate the effects of levetiracetam (LEV) on cognitive network activations in patients with drug-resistant temporal lobe epilepsy (TLE).
Results:
We isolated task-and syndrome-specific effects. Patients on LEV showed normalization of functional network deactivations in the right temporal lobe in right TLE during the right-lateralizing visual-spatial task and in the left temporal lobe in left TLE during the verbal task. In a post hoc analysis, a significant dose-dependent effect was demonstrated in right TLE during the visual-spatial WM task: the lower the LEV dose, the greater the abnormal right hippocampal activation. At a less stringent threshold (p , 0.05, uncorrected for multiple comparisons), a similar dose effect was observed in left TLE during the verbal task: both hippocampi were more abnormally activated in patients with lower doses, but more prominently on the left.
Conclusions: Our findings suggest that LEV is associated with restoration of normal activation patterns. Longitudinal studies are necessary to establish whether the neural patterns translate to drug response.
Classification of evidence:
This study provides Class III evidence that in patients with drugresistant TLE, levetiracetam has a dose-dependent facilitation of deactivation of mesial temporal structures. Neurology ® 2014;83:1508-1512 GLOSSARY BOLD 5 blood oxygenation level-dependent; CBZ 5 carbamazepine; fMRI 5 functional MRI; GLM 5 general linear model; HS 5 hippocampal sclerosis; JME 5 juvenile myoclonic epilepsy; LEV 5 levetiracetam; LTG 5 lamotrigine; NHNN 5 National Hospital for Neurology and Neurosurgery; TLE 5 temporal lobe epilepsy; TPM 5 topiramate; VPA 5 valproate; WM 5 working memory; ZNS 5 zonisamide.
In a previous working memory (WM) functional MRI (fMRI) study, we observed a valproate (VPA) dose-dependent normalization of impaired deactivation within the motor system in patients with juvenile myoclonic epilepsy (JME). 1 During the same task, patients with temporal lobe epilepsy (TLE) due to hippocampal sclerosis (HS) failed to deactivate the diseased hippocampus with increasing cognitive demands, 2 which was associated with poor performance. 2, 3 Levetiracetam (LEV) is efficacious in focal epilepsies with a positive cognitive side effect profile. 4, 5 The aim of this retrospective study was to assess the effect of LEV on fMRI activation and deactivation patterns during WM tasks in patients with TLE. We hypothesized that patients on LEV show greater deactivation within temporal lobe epileptogenic networks compared to those without LEV. MRI data acquisition and fMRI paradigms. MRI scans were obtained with a GE (Little Chalfont, UK) Excite HDx 3T scanner.
METHODS

1
We employed modified versions of the n-back WM task. In the visual-spatial task, subjects monitor the sequence of dots randomly appearing in 4 different locations on a screen. Participants are instructed to move a joystick to the current position of the dot (0-back) or to the positions 1 or 2 presentations earlier (1-or 2-back). 6 In the verbal task, a sequence of words was presented. Participants had to respond using a joystick whenever they read the word bird (control condition) or whenever a word had been displayed 2 presentations earlier (2-back condition).
MRI data analysis. A priori models were chosen with regard to our experimental design. Models were estimated using a general linear model (GLM) implemented in SPM8 (Statistical Parametric Mapping; www.fil.ion.ucl.ac.uk/spm). The GLM then estimated which voxels with greater change in blood oxygenation leveldependent (BOLD) signal fit which condition specified in the model, i.e., the BOLD signal was the outcome variable.
Both tasks were of a blocked design and modeled at a singlesubject level using a boxcar function for each of the conditions. We created contrast images for each subject to explore the patterns of activation and deactivation in both tasks. For the taskrelated activations, contrasts comparing the most difficult WM condition with the control task were generated ("2-minus 0-back" and "2-back minus Is-it-bird?"). For task-related deactivations, we used the opposite contrasts ("0-minus 2-back" and "Is-it-bird? minus 2-back"). We excluded 9 patient datasets due to lack of activation.
To explore task-specific effects of LEV at a group level, a fullfactorial design with group and LEV treatment as factors was built. All other AEDs, and presence or absence or HS, were entered as covariates of no interest to control for extra variability between groups.
In a post hoc analysis, task-related deactivation patterns were correlated with the daily LEV dose: right TLE median (interquartile range) 2,500 (1,000) mg, left TLE 2,500 (1,000) mg; MannWhitney U test p 5 0.860. All patients divided the daily dose into morning (8) (9) (10) and evening dose (6) (7) (8) .
The level for significance was p , 0.001 uncorrected with a 20-voxel threshold extent. 7 Cognitive measures. Standardized frontal lobe tests were administered (table 2). As cognitive outcome variables we used verbal IQ, raw scores for category and verbal fluency, digit span backwards, and Wisconsin Card Sorting Test categories. We isolated task-and syndrome-specific LEV effects on deactivation patterns (figure 1). Patients on LEV and 28 healthy controls from a previous study 2 showed similar patterns of deactivation. Compared to patients without LEV, those on LEV showed an augmentation of task-related deactivation in the affected temporal lobe, i.e., left midtemporal gyrus in left TLE during the verbal and right hippocampus in right TLE during the visualspatial task (figure 1B). The reverse contrast (on LEV . no LEV) showed no effect for either WM paradigm (not shown).
No LEV effect was observed in left TLE during the visual-spatial and or right TLE during the verbal WM task.
We conducted the same analysis in patients treated with CBZ (22 left, 20 right TLE) or LTG (18/ 17) vs those without CBZ (31/34) or LTG (35/37). No comparable effects were observed.
In a post hoc analysis, a significant dosedependent LEV effect was demonstrated ( figure 1C ) in right TLE during the visual-spatial WM task: the lower the LEV dose, the lesser the right hippocampal deactivation. At a less stringent threshold (p , 0.05, uncorrected for multiple comparisons), a similar dose effect was observed in left TLE during the verbal task ( figure 1C ). DISCUSSION We demonstrate a dose-dependent, task-specific effect of LEV on functional network activations in TLE.
Progressive deactivation of mesial temporal structures during cognitive tasks has been associated with improved performance in healthy controls and patient cohorts. 2, 3, 8 LEV's dose-dependent facilitation of the deactivation in this study suggests a beneficial drug effect on cognitive networks in TLE. Since WM performance was equal across groups, the observed effect was not influenced by performance.
Underlying HS was more frequent in patients with left TLE on LEV than in all other groups, but HS distribution did not differ between patients with right TLE on or without LEV (x 2 5 0.352, p 5 0.352). We controlled for the effect of HS diagnosis, which ensures that our findings are not driven by the difference in HS frequencies.
Dose dependence was more apparent in the more demanding nonverbal task. To ensure adequate performance in the 2-back condition of the dot-back task, a greater task-related deactivation may be required. We did not find similar effects for CBZ or LTG, suggesting our findings are LEV-specific.
Longitudinal data are lacking to determine whether LEV led to seizure reduction or improvement of cognitive functions. A further limitation is the number of AED combinations, although distribution was equal for the most commonly prescribed other AEDs.
Our findings in TLE are consistent with previous findings in juvenile myoclonic epilepsy showing a valproate dose-dependent reduction of abnormal motor system coactivation and enhanced WM activations.
These effects were not associated with better performance or seizure control, but suggest that AEDs affect epileptogenic and cognitive networks differentially. Our sample included only drug-resistant patients, thus it would be important to establish whether the neural patterns observed here translate to drug-responsive patients with TLE in a longitudinal study.
